Preview Mode Links will not work in preview mode

Psychopharmacology and Psychiatry Updates

Dec 28, 2022

In this episode, we review the current literature on the association between exercise and the risk for depression. Specifically, how much physical activity is associated with a lower risk for depression? We also discuss the World Health Organization recommendations for the ideal range of physical activity.

Faculty: Jim...


Dec 23, 2022

In this episode, we discuss treatment options for managing psychosis and schizophrenia in children and adolescents, including the FDA-approved antipsychotics for this population. We also explain medication dosing guidelines and monitoring recommendations. 

Faculty: David Rosenberg, M.D.
Host: Richard Seeber, M.D.


Dec 18, 2022

Are antidepressants in adolescent depression associated with an increased risk for suicidality? In this episode, we discuss the particularities of adolescent depression, including some statistics and the risk of suicide when using antidepressants in this population.

Faculty: David Rosenberg, M.D.
Host: Richard Seeber,...


Dec 13, 2022

In this episode, we discuss the diagnosis of psychotic symptoms in children and adolescents, including the differences between primary and secondary psychosis and the rating scales for assessing these symptoms. 

Faculty: David Rosenberg, M.D.
Host: Richard Seeber, M.D.


Dec 8, 2022

Can L-methylfolate help in depression treatment? Should we indicate it to all patients with depression? In this episode, we discuss the metabolic pathways for folic acid, when to indicate L-methylfolate, and when to perform genetic testing for methyltetrahydrofolate reductase (MTFR) enzymes. 

Faculty: Jim Phelps,...